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Objective: to report the outcome of patients with venous stasis ulceration (VSU) and severe arterial occlusive disease
(AOD).
Design: retrospective study.
Methods: using the International Classification of Diseases (ICD-9), codes for VSU and AOD were cross-matched to
identify patients from 1989 to 1999 at two tertiary hospitals. Entry into the study required the presence of a VSU and an
ipsilateral procedure to improve AOD or major amputation during the same hospitalisation.
Results: fourteen patients (15 extremities) with a mean age of 80 years (range: 47±93) were identified as having VSU and
AOD. Mean duration of VSU up to the time of revascularisation or amputation was 6.4 years (range: 4 months±21 years).
The mean number of VSUs per extremity was 2.1 and mean wound area was 71 cm2. Mean ankle±brachial index was
0.46 (range: 0.10±0.78). Nine extremities (60%) had a bypass procedure, 3 (20%) had an interventional procedure, 1 (0.6%)
had a lumbar sympathectomy, and 2 (13%) had an amputation. Over a mean follow-up of 2.8 years, 3 extremities (23%)
healed of which 2 recurred. On last review, 11 patients with 12 afflicted extremities had expired. Nine of the remaining
10 extremities were not healed at the time of death. Eight of nine bypass grafts remained patent in follow-up or at death and
subsequent limb salvage was 100%.
Conclusions: combined VSU and AOD represents a rare condition predominantly found in elderly patients with multiple
comorbidities. Few patients had complete healing despite an arterial inflow procedure and mortality was high over the
short term.
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Lower extremity ulceration arising from chronic ven-
ous insufficiency afflicts as much as one per cent of
the adult population.1±3 Although various surgical
interventions are available for treatment,4±11 the large
majority of patients are prescribed some form of
elastic compression.12,13 Healing often occurs with
compliance but unfortunately recurrence rates for
venous stasis ulceration (VSU) remain as high as
60%.12,14 Other factors such as poor nutrition,
immunosuppression, and ulcer size, may contribute
to VSUs becoming recalcitrant.15,16 Additionally, the
presence of arterial occlusive disease (AOD) from
atherosclerosis may further complicate healing.17,18
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arterial perfusion is provided.18,19 Knowledge as to
the outcome of patients with VSU and AOD necessi-
tating a procedure to improve arterial inflow remains
limited. Herein, we report the long-term outcome of
patients with these two morbid conditions.
Patients and Methods
A retrospective chart review was performed at
Memorial Medical Center and St John's Hospital in
Springfield, Illinois. Each hospital functions as
tertiary referral center for Central and Southern
Illinois as well as the primary teaching hospitals for
Southern Illinois University, School of Medicine.
Patients were identified by using the International
Classification of Diseases, 9th Revision (ICD-9). As
required by the Centers for Medicare and Medicaidcience Ltd
250 W. T. Bohannon et al.Services for the purposes of reimbursement and data
collection for each hospital, all ICD-9 codes are
applied to every patient's discharge by registered
health information technicians in the Department of
Medical Records. In order to identify patients with
concomitant VSU and AOD at the same hospital
discharge, a list of patients was computer generated
(St. John's Hospital: Chart Stat, SoftMed; Memorial
Medical Center: Crystal Applications, Seagate) where-
by ICD-9 codes applicable to chronic venous insuffi-
ciency and atherosclerosis of the lower extremity
were cross-matched in all combinations for hospital
discharges between 1989 and 1999. Multiple codes
were used in order to maximise the ability to find
patients with both conditions at the same hospital
discharge. Table 1 shows the ICD-9 codes used for
cross-matching.
After patient identification by having at least one
ICD-9 code related to venous insufficiency and ath-
erosclerosis of the lower extremity, charts were com-
pletely reviewed by the senior author (R.B.M.) or the
vascular surgery fellow (W.T.B) for patients hospita-
lised with an active VSU and the presence of AOD
during the same hospitalisation. VSU was defined by
the presence of ulceration at or near the medial or
lateral malleoli. Information as to the presence of
edema, hyperpigmentation, stasis dermatitis, and
lipodermatosclerosis was sought. To increase the
likelihood of a clinical diagnosis of VSU, at least two
of these additional signs had to be present. Other
information obtained regarding the patient's venous
disease included pertinent demographic data, risk
factors, and ulcer size and duration. Patients with
ulcers secondary to trauma, caused by primary infec-
tion, or thought to be solely related to diabetes melli-
tus were excluded.Table 1. ICD-9 codes applicable to chronic venous insufficiency
and atherosclerosis of the lower extremity. ICD-9 codes were
cross-matched in all combinations.
ICD-9 codes: chronic venous insufficiency
Varicose veins of lower extremity with ulcer 454.0
Varicose veins of lower extremity with inflammation 454.1
Postphlebitic syndrome 459.1
Venous insufficiency 459.81
Chronic ulcer of skin, lower limb, except decubitus 707.1
Chronic ulcer of other specified site 707.8
Chronic ulcer of unspecified site 707.9
ICD-9 codes: atherosclerosis of the lower extremity
Atherosclerosis of native arteries of the extremities 440.2
Atherosclerosis of bypass graft of the extremities 440.3
Peripheral vascular disease, unspecified 443.9
 ICD-9 International Classification of Diseases, 9th revision.
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defined as those undergoing a procedure to improve
arterial circulation or having an amputation. Add-
itionally, at least one objective test documenting the
severity of AOD prior to the procedure was required
for inclusion. These included ankle±brachial index
(ABI), toe pressures, arterial duplex mapping, or
arteriography. Pulse examination was not considered
an objective assessment. Demographic data, risk fac-
tors, functional status, and other signs and symptoms
pertinent to AOD were recorded.
Follow-up information was obtained by continued
review of subsequent inpatient and outpatient
records. Final follow-up was performed by telephone
interview with the patient. If the patient was deceased
or not able to be interviewed, persons noted in the
medical record as a patient contact were interviewed if
possible. Follow-up information included ulcer heal-
ing and recurrence, durability of arterial inflow pro-
cedure, functional status, and disposition.
Results
From 1989 to 1999, a total of 456 199 patients were
discharged from Memorial Medical Center and
St. John's Hospital. Of these, ICD-9 cross-matching
identified 367 patients with concomitant codes related
to chronic venous insufficiency and atherosclerosis
of the lower extremity. Review of these charts re-
vealed 14 patients (15 extremities) as having VSU
and an arterial inflow procedure or amputation for
severe AOD during the same hospitalisation. Mean
age was 80 years (range: 47±93) and nine patients
(64%) were female. Four patients (29%) had a remote
history of lower extremity deep venous thrombosis, 3
(21%) had a remote history of varicose vein stripping,
and 4 (29%) had a remote history of lower extremity
trauma. Nine patients (64%) smoked, 12 (86%) had
hypertension, 5 (36%) had diabetes mellitus, 4 (29%)
had hyperlipidaemia, 2 (12%) had chronic renal insuf-
ficiency (baseline creatinine4 2.5 mg/dl), and 10
(71%) had coronary artery disease. Mean duration of
VSU up to the time of arterial inflow procedure or
amputation was 6.4 years (range: 4 months±21
years). Mean VSUs per extremity was 2.1 with a
mean wound area of 71 cm2 (range: 1.8±360 cm2).
Four extremities (27%) had ipsilateral toe ulceration.
Objective measurement of AOD prior to arterial in-
flow procedure or amputation included ABI in
12 extremities, toe pressures in 9 and arteriography
in 13. Table 2 shows results of tests measuring arterial
insufficiency before and after arterial inflow proced-
ure or amputation.
Table 2. Diabetes status, non-invasive vascular testing, arteriogram findings, and type of arterial inflow procedure or amputation for
each patient with concomitant venous stasis ulcer and severe atherosclerotic occlusive disease of the lower extremity. Patient LJ is
shown twice because both extremities were affected.
Patient (age) Diabetes Pre-ABI/
toe pressure
Arteriogram findings Inflow procedure/
amputation
Post-ABI/
toe pressuresy
FA (86) yes 0.61/31 Popliteal artery occlusion Femoral±popliteal bypass none/67
WB (77) no None/none Superficial femoral artery occlusion Femoral±popliteal bypass none/none
KB (47) no 0.48/30 Common iliac stenosis, 90% PTAz 1.08/80
VB (91) no 0.55/28 Superficial femoral artery stenosis, 70%
popliteal artery stenosis, 50%
diffuse tibial artery stenoses
Femoral±popliteal bypass none/66
BG (83) yes 0.0/14 Diffuse tibial artery stenoses PTA (failed)
popliteal±tibial bypass
1.06/84
LJ (82) no 0.3/none Common femoral artery stenosis, 50%
superficial femoral artery occlusion
diffuse tibial artery stenoses
Femoral±tibial bypass 1.20/100
LJ (82) no 0.3/none Common femoral artery stenosis, 30%
superficial femoral artery stenosis, 90%
diffuse tibial artery stenoses
Femoral±tibial bypass 1.10/90
RK (63) no 0.83/0 Superficial femoral artery occlusion Femoral±popliteal bypass 0.94/60
MK (91) no None/none Superficial femoral artery stenosis, 90%
popliteal artery stenosis, 90%
Lumbar sympathectomy None/none
LM (76) yes 0.4/30 Diffuse tibial artery stenoses Femoral±tibial bypass 0.55/24
JR (77) no 0.45/15 Superficial femoral artery stenosis, 90% Femoral±popliteal bypass None/none
BW (77) yes 0.78/76 Common iliac stenosis, 70% PTAz 0.80/85
DW (83) yes NC/none Superficial femoral artery stenosis, 95%
diffuse tibial artery stenoses
PTAz, lumbar sympathectomy NCx/63
CW (88) no 0.4/24 Superficial femoral artery stenosis, 95% Above knee amputation Not applicable
MZ (93) no 0.5/none None Above knee amputation Not applicable
pre-ABI ankle±brachial index prior to arterial inflow procedure or amputation, toe pressures measured in mmHg.
y post-ABI ankle±brachial index after arterial inflow procedure or amputation (same hospitalisation), toe pressures measured in mmHg.
z PTApercutaneous transluminal angioplasty.
x NCnon-compressible.
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arterial inflow and 2 patients underwent above
knee amputation. Of the 12 patients (13 extremities)
having an arterial inflow procedure, 9 had a bypass
(7 with vein, 2 with synthetic graft), 4 had a percutan-
eous transluminal angioplasty (PTA), and 2 had a
lumbar sympathectomy. One patient failed PTA of
the tibioperoneal trunk and underwent bypass.
One patient had a lumbar sympathectomy following
PTA during the same hospitalisation. Table 2 shows
the type of bypass and location of PTA for each
patient.
Over a mean follow-up of 2.8 years (range: 0.25±11
years), complete VSU healing occurred in only
3 extremities (3 patients, 21%). Two of these extrem-
ities experienced recurrent ulceration. The patient
who remained healed at last follow-up had moderate
arterial insufficiency and underwent common iliac
artery PTA (patient BW, Table 2). At last follow-up or
death (mean: 2.8 years), 8 of 9 bypasses were patent.
Two bypasses occluded in follow-up. One bypass
occluded 4 months postoperatively and underwent
successful thrombolysis and PTA of a common iliac
stenosis and the other bypass occluded 10 monthspostoperatively and failed thrombolysis. Of those
patients undergoing only PTA, one had a repeat
superficial femoral artery PTA one month later. No
patient who had an arterial inflow procedure went
on to amputation at last follow-up or death. At last
follow-up, 11 of 14 patients were dead and of those
12 who had an arterial inflow procedure, only one
had permanent VSU healing. This patient died with
a healed extremity and no recurrence. Mean time to
death was 33 months (range: 3±132 months). Causes of
death included myocardial infarction in 3 patients,
congestive heart failure in 2 patients, pulmonary em-
bolism in one patient, stroke in one patient, and
sepsis from an infected VSU in one patient. Cause of
death in the remaining 3 patients could not be
determined. The youngest patient who underwent
a common iliac artery PTA was lost to follow-up
(patient KB, Table 2).
Prior to arterial inflow procedure or amputation,
12 of 14 patients were ambulatory of which 8 required
a walker or cane. Following recovery from an arterial
inflow procedure, two patients no longer required
a walker or cane and one patient who could walk
independently required a walker. At last follow-upEur J Vasc Endovasc Surg Vol 24, September 2002
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3 required a walker.
Prior to arterial inflow procedure or amputation,
10 patients lived at home, 2 resided in an assisted
living facility resided, and 2 were cared for in a skilled
nursing facility. Both patients who underwent
amputation lived in a skilled nursing facility before
and after the procedure. During recovery after an
arterial inflow procedure (n 12 patients), 3 patients
required a skilled nursing facility and 4 had profes-
sional home health care. The two patients who were
in an assisted living facility prior to the procedure
were discharged to a skilled nursing facility. At last
follow-up or death, 8 of 14 resided in a skilled
nursing facility of which 6 patients declined in their
disposition status.
Discussion
Treatment of VSU can be time consuming, expensive,
and frustrating for both the patient and physician.15,20
Although various surgical procedures are avail-
able to assist in healing a VSU,4±11,21 the mainstay of
therapy remains elastic compression because of
equivalent results in healing.12 Patients with concom-
itant arterial insufficiency may not tolerate compres-
sion secondary to exacerbation of inadequate arterial
perfusion that may lead to increased pain and poor
healing.18 Little is known about the outcome of
patients who have a VSU and severe AOD. The pur-
pose of this study was to examine the patient charac-
teristics and outcome of those with a presumed
clinical diagnosis of VSU and concomitant severe
AOD requiring an intervention, be it an arterial
inflow procedure or amputation.
Although patients presenting solely with VSU or
AOD of the lower extremity represent relatively
common conditions, patients afflicted with VSU and
severe AOD seem to be an extremely rare cohort, as
exemplified in this study. Patients with these two
conditions represented 0.08% of all discharges at
two large tertiary care hospitals over a ten-year time
period. Knowledge of how many patients in the com-
munity had VSU over the same time frame would
provide a more accurate denominator of how fre-
quently severe ipsilateral AOD occurs. Nevertheless,
14 patients represent a very small group of patients
having both conditions whereby a procedure was
performed for AOD. Ghauri et al. showed that of
267 consecutive extremities with VSU, 33 (12%) had
moderate arterial insufficiency (ABI4 0.5 and 5 0.85)
and 13 (5%) had severe arterial insufficiency (ABI5
0.5).17 Of these 46 patients, 14 required an arterialEur J Vasc Endovasc Surg Vol 24, September 2002inflow procedure. Thirty-six week healing rates in
these two groups were 64% and 23% respectively.
The large majority of patients in our study had severe
arterial insufficiency as defined by Ghauri et al.
and healing was equally poor. Other studies have
shown a similar prevalence of AOD complicating
VSU. Callam et al. demonstrated in a large study
population that 19% of proximal leg ulcers had con-
comitant arterial insufficiency (ABI5 0.9) and of
those patients with arterial impairment and ulcer-
ation, 52% had other physical signs of chronic venous
insufficiency.22 Nelzen et al., in a large cross-sectional
population study designed to determine the aetiology
of chronic leg ulceration (n 463 extremities), found
that 72% had venous insufficiency and 40% had arter-
ial insufficiency (ABI5 0.9), thus representing an
overlap of 12%.3
Compared to other studies examining the natural
history of VSU,6,13±15 patients in this study with com-
bined disease were predominantly older (mean age:
80 years) with a higher mortality (mean time to death
of 11/14 patients: 33 months). Interestingly, patients
solely with limb-threatening AOD also are younger
with better survival than this small cohort of pat-
ients with combined disease.22 Callam et al. noted in
the aforementioned study that the probability of
having a chronic leg ulcer associated with arterial
insufficiency rises sharply with age.23 By the ninth
decade, 50% of patients had associated arterial insuf-
ficiency. Another predominant feature of our pat-
ients was the relatively high frequency of risk factors
for the development of chronic venous insufficiency
and atherosclerosis, thus supporting the potential
pathogenesis of both conditions over time. Diabetes
was evenly distributed among the 14 patients
(Table 2). Two patients had an ABI5 0.5 while
2 patients had ABI4 0.5 and5 0.8, and 1 patient
had non-compressible arteries. Similarly, there was
no trend as to patients with diabetes having larger
ulcers and no patient with diabetes required amputa-
tion as the initial treatment. Three patients underwent
arterial bypass surgery and two had percutaneous
transluminal angioplasty.
Given the older age and multiple comorbidities of
this patient group, the poor outcome of ulcer healing
and high mortality over the short term is not sur-
prising. Limb salvage for those patients undergoing
an arterial inflow procedure was 100%. Ironically,
after recovery over the short term, patients continued
to ambulate with or without assistance. These mixed
results present a dilemma in deciding whether some
patients would be better served with an amputation
instead of an arterial inflow procedure, particularly
when that procedure is bypass surgery. Defining the
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able ancillary support services becomes paramount in
recommending the most appropriate therapy. With
regard to ulcer healing, Marston et al. in a prospective
study determined that the only factors to independ-
ently affect healing time were initial ulcer size and the
presence of moderate arterial insufficiency (ABI4 0.5
and5 0.8).15 Patients with severe ischaemia
(ABI5 0.5) underwent revascularisation as is recom-
mended in our practice. Average ulcer size in
their study was 24.6 cm2 compared to 71 cm2 in our
study.
Given that VSU healing may be dependent upon
the presence of arterial occlusive disease, all
patients should undergo a pulse examination. If a
pedal pulse cannot be easily detected, which is not
uncommon given the possible presence of oedema
and/or lipodermatosclerosis, an ABI should be per-
formed. Taking into account other comorbidities,
patients with VSU and severe ischaemia (ABI5 0.5)
should undergo revascularisation whereas those with
moderate ischaemia (ABI4 0.5 and5 0.8) require se-
lective revascularisation depending on VSU recalci-
trance and size.
The reliability of the ICD-9 coding system to accur-
ately identify all patients with both diseases at dis-
charge may represent one weakness of the study.
Indeed, all patients discharged with VSU were not
routinely evaluated for the presence of AOD. Our
goal was to examine the natural history of those
patients with VSU who additionally underwent arter-
ial revascularisation or amputation because of AOD.
Other studies have used the ICD-9 coding system
to identify patients with reliable results.24±26 The lack
of objective testing to measure venous insufficiency
such as the measurement of venous valve closure
times or venous refill times remains a shortcoming
of the study. Nevertheless, older reports examining
the clinical science of VSU often relied on physical
examination alone as non-invasive vascular labora-
tory testing was not developed.12,27,28 Because of the
retrospective nature of the study, patients were
required to have at least two other physical signs
of chronic venous insufficiency documented in the
medical record in addition to the presence of a mal-
leolar ulcer and a discharge diagnosis of VSU. Lastly,
little insight can be made as to the treatment of the
VSU after the arterial inflow procedure was per-
formed and whether wound complications occurred
after bypass surgery. There was no physician uniform-
ity as the study examined two entire hospital popula-
tions over a ten-year period.
In summary, patients with VSU and severe AOD
who need an arterial inflow procedure or amputationare elderly, have multiple comorbidities, and a high
mortality during the short term. With the treatment
of arterial inflow in this study, ulcer healing is infre-
quent but limb salvage remains high. Preprocedure
ambulatory status, available ancillary services, and
patient desires may represent the most important fac-
tors in deciding whether to recommend amputation or
provide a surgical bypass. The minimal invasiveness
and low risks associated with endoluminal therapies
should direct the physician to aggressively pursuing
this treatment to improve arterial inflow if possible.
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